Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

FDA Document: Pfizer Admits 5-Year Study & Larger Sample Size Required to Determine Myocarditis Risk Injecting 5-12 Year-Olds


1,692 views

Parents, it’s critical for the sake of your children to stay informed of what the medical authoritarians want to inject into our youth.

Children have a 99.9973% COVID-19 survival rate.

The latest data indicates this virus presents zero risk to healthy children.

https://twitter.com/DonMcglashen/status/1459675959720878083

Yet, governments have rushed this experimental injection for kids as young as 5 years old.

The propaganda campaign to inject every child 5-12 is relentless, even though Pfizer and FDA regulators admit they don’t know the injection’s safety profile.

Dr. Eric Rubin, Harvard professor and editor-in-chief of the New England Journal of Medicine, verbally admitted they don’t know the safety of the COVID-19 formula for children:

After digging through the FDA’s Vaccines And Related Biological Products Advisory Committee Briefing Document, it’s clear Pfizer doesn’t know the safety profile.

Pfizer admitted their clinical trials were too short to determine the long-term risk of myocarditis/pericarditis for children 5 to <12.

A 5-year follow-up study is required to thoroughly understand the long-term risk of myocarditis/pericarditis.

Pfizer also noted the sample size of its clinical trial was too small to detect the risk of myocarditis after inoculation for this age bracket.

The information is buried on page 11 of the FDA document.

https://twitter.com/Charlie92975974/status/1460433116258979842

I took a screenshot in case Twitter decided to delete the photo:

From FDA.gov:

The number of participants in the current clinical development program is too small to detect
any potential risks of myocarditis associated with vaccination. Long-term safety of COVID-19 vaccine in participants 5 to <12 years of age will be studied in
5 post-authorization safety studies, including a 5-year follow-up study to evaluate long term sequelae of post-vaccination myocarditis/pericarditis.

Infowars added:

Despite this, the FDA last month issued emergency use authorization for Pfizer-BioNTech’s COVID-19 vaccine to be given to children between the ages of five and 11.

Meanwhile, the FDA has delayed a similar EUA for Moderna citing a need to conduct a more thorough examination into myocarditis risks.

The company’s vaccine formulation for youngsters contains tromethamine, a drug added with little fanfare that’s “used to treat metabolic acidosis, which often “occurs after heart bypass surgery or cardiac arrest,” according to Kaiser Permanente.

 



 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!